2025 Q3 -tulosraportti
22 päivää sitten23 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
7 087
Myynti
Määrä
19 985
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 15 | - | - | ||
| 5 | - | - | ||
| 289 | - | - | ||
| 7 000 | - | - | ||
| 19 214 | - | - |
Ylin
1,09VWAP
Alin
1,06VaihtoMäärä
0,2 201 302
VWAP
Ylin
1,09Alin
1,06VaihtoMäärä
0,2 201 302
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 18.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11. | |
| 2025 Q2 -tulosraportti | 15.8. | |
| 2025 Q1 -tulosraportti | 8.5. | |
| 2024 Q4 -tulosraportti | 20.3. | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·2 päivää sitten108 days until earnings report. Unfortunately, I don't think the next earnings report will be a turning point. So right now I'm playing with Novo Nordisk while I'm out. And I'm well on my way to recovering some of what I lost on BioPorto. I am in profit relative to what I have invested, so I will stay here a little longer. I am quite interested in BioPorto after all. Right now, however, I am out...
·14 t sittenBoth people on the executive floor and the board have bought shares in BP, and it is known that the chairman of the board has bought shares for several million kroner. It is a signal to send to the outside world that they believe in the project.- ·2.12.BioPorto - Outside-in perspectives from newly appointed CEO - 1.12.2025 https://www.youtube.com/watch?v=_mlnAFWKyhI·3.12.I am rather indifferent whether the company communicates openly or closed, if only the company could show progress in sales. For the 15th year, the company is idling or even going backwards. Without progress, the company is dying.
·25.11.Bioporto`s chairman of the board is probably one of the chairmen I have seen for a very long time who, through financial action, believes most in the company he is chairman of. He has namely in the recently concluded share issue personally bought shares for a total of 3 mill kr. What is fantastic is that he also back in arpril when there was a share issue on 25 april bought shares for 4 mill kr. And it is thereby not just the "usual" obligatory purchases of 3-400.000 that many chairmen/members most often only buy for. On that basis I myself yesterday increased my Bioporto investment by a full 33 %.·3.12.Yes, both downgrades ARE noted. Let's catch up by July 2026 when they have an approved FDA application.- ·24.11.Bioporto's board and directors buy shares in BP https://www.globenewswire.com/news-release/2025/11/24/3193260/0/en/Managers-transactions.html
·28.11.Nothing new in buying up well in advance of the FDA application. Minimum 100% to gain.·6.12.If you have held the stock for approx 13 years, we can quickly establish that you have not had 100 % in profit at any time but rather a loss of 60 %.... 
·24.11. · MuokattuIsn't it strange that all shareholders haven't had the opportunity to participate in the share issue which has now concluded, and which dilutes existing shares by 8 %?
·1 päivä sitten · MuokattuALL offerings should have a reparation element for private investors, where one has the opportunity to buy on the same terms. However, these must be non-convertible warrants, so one doesn't end up in a shit-show of falling prices. In other words: We have raised 5% via II at price X; private investors can therefore also buy 5% at price X by using warrants (1 per 20 shares) within 11 trading days. How FUCKING difficult can it be? Should there be a sweetener (if II has received warrants, e.g., 10% of new shares at price *2 with 2 years vesting, then private investors should, of course, have the same benefit).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
22 päivää sitten23 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten108 days until earnings report. Unfortunately, I don't think the next earnings report will be a turning point. So right now I'm playing with Novo Nordisk while I'm out. And I'm well on my way to recovering some of what I lost on BioPorto. I am in profit relative to what I have invested, so I will stay here a little longer. I am quite interested in BioPorto after all. Right now, however, I am out...·14 t sittenBoth people on the executive floor and the board have bought shares in BP, and it is known that the chairman of the board has bought shares for several million kroner. It is a signal to send to the outside world that they believe in the project.
- ·2.12.BioPorto - Outside-in perspectives from newly appointed CEO - 1.12.2025 https://www.youtube.com/watch?v=_mlnAFWKyhI·3.12.I am rather indifferent whether the company communicates openly or closed, if only the company could show progress in sales. For the 15th year, the company is idling or even going backwards. Without progress, the company is dying.
- ·25.11.Bioporto`s chairman of the board is probably one of the chairmen I have seen for a very long time who, through financial action, believes most in the company he is chairman of. He has namely in the recently concluded share issue personally bought shares for a total of 3 mill kr. What is fantastic is that he also back in arpril when there was a share issue on 25 april bought shares for 4 mill kr. And it is thereby not just the "usual" obligatory purchases of 3-400.000 that many chairmen/members most often only buy for. On that basis I myself yesterday increased my Bioporto investment by a full 33 %.·3.12.Yes, both downgrades ARE noted. Let's catch up by July 2026 when they have an approved FDA application.
- ·24.11.Bioporto's board and directors buy shares in BP https://www.globenewswire.com/news-release/2025/11/24/3193260/0/en/Managers-transactions.html·28.11.Nothing new in buying up well in advance of the FDA application. Minimum 100% to gain.·6.12.If you have held the stock for approx 13 years, we can quickly establish that you have not had 100 % in profit at any time but rather a loss of 60 %....
- ·24.11. · MuokattuIsn't it strange that all shareholders haven't had the opportunity to participate in the share issue which has now concluded, and which dilutes existing shares by 8 %?·1 päivä sitten · MuokattuALL offerings should have a reparation element for private investors, where one has the opportunity to buy on the same terms. However, these must be non-convertible warrants, so one doesn't end up in a shit-show of falling prices. In other words: We have raised 5% via II at price X; private investors can therefore also buy 5% at price X by using warrants (1 per 20 shares) within 11 trading days. How FUCKING difficult can it be? Should there be a sweetener (if II has received warrants, e.g., 10% of new shares at price *2 with 2 years vesting, then private investors should, of course, have the same benefit).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
7 087
Myynti
Määrä
19 985
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 15 | - | - | ||
| 5 | - | - | ||
| 289 | - | - | ||
| 7 000 | - | - | ||
| 19 214 | - | - |
Ylin
1,09VWAP
Alin
1,06VaihtoMäärä
0,2 201 302
VWAP
Ylin
1,09Alin
1,06VaihtoMäärä
0,2 201 302
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 18.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11. | |
| 2025 Q2 -tulosraportti | 15.8. | |
| 2025 Q1 -tulosraportti | 8.5. | |
| 2024 Q4 -tulosraportti | 20.3. | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
2025 Q3 -tulosraportti
22 päivää sitten23 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 18.3.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11. | |
| 2025 Q2 -tulosraportti | 15.8. | |
| 2025 Q1 -tulosraportti | 8.5. | |
| 2024 Q4 -tulosraportti | 20.3. | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten108 days until earnings report. Unfortunately, I don't think the next earnings report will be a turning point. So right now I'm playing with Novo Nordisk while I'm out. And I'm well on my way to recovering some of what I lost on BioPorto. I am in profit relative to what I have invested, so I will stay here a little longer. I am quite interested in BioPorto after all. Right now, however, I am out...·14 t sittenBoth people on the executive floor and the board have bought shares in BP, and it is known that the chairman of the board has bought shares for several million kroner. It is a signal to send to the outside world that they believe in the project.
- ·2.12.BioPorto - Outside-in perspectives from newly appointed CEO - 1.12.2025 https://www.youtube.com/watch?v=_mlnAFWKyhI·3.12.I am rather indifferent whether the company communicates openly or closed, if only the company could show progress in sales. For the 15th year, the company is idling or even going backwards. Without progress, the company is dying.
- ·25.11.Bioporto`s chairman of the board is probably one of the chairmen I have seen for a very long time who, through financial action, believes most in the company he is chairman of. He has namely in the recently concluded share issue personally bought shares for a total of 3 mill kr. What is fantastic is that he also back in arpril when there was a share issue on 25 april bought shares for 4 mill kr. And it is thereby not just the "usual" obligatory purchases of 3-400.000 that many chairmen/members most often only buy for. On that basis I myself yesterday increased my Bioporto investment by a full 33 %.·3.12.Yes, both downgrades ARE noted. Let's catch up by July 2026 when they have an approved FDA application.
- ·24.11.Bioporto's board and directors buy shares in BP https://www.globenewswire.com/news-release/2025/11/24/3193260/0/en/Managers-transactions.html·28.11.Nothing new in buying up well in advance of the FDA application. Minimum 100% to gain.·6.12.If you have held the stock for approx 13 years, we can quickly establish that you have not had 100 % in profit at any time but rather a loss of 60 %....
- ·24.11. · MuokattuIsn't it strange that all shareholders haven't had the opportunity to participate in the share issue which has now concluded, and which dilutes existing shares by 8 %?·1 päivä sitten · MuokattuALL offerings should have a reparation element for private investors, where one has the opportunity to buy on the same terms. However, these must be non-convertible warrants, so one doesn't end up in a shit-show of falling prices. In other words: We have raised 5% via II at price X; private investors can therefore also buy 5% at price X by using warrants (1 per 20 shares) within 11 trading days. How FUCKING difficult can it be? Should there be a sweetener (if II has received warrants, e.g., 10% of new shares at price *2 with 2 years vesting, then private investors should, of course, have the same benefit).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
7 087
Myynti
Määrä
19 985
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 15 | - | - | ||
| 5 | - | - | ||
| 289 | - | - | ||
| 7 000 | - | - | ||
| 19 214 | - | - |
Ylin
1,09VWAP
Alin
1,06VaihtoMäärä
0,2 201 302
VWAP
Ylin
1,09Alin
1,06VaihtoMäärä
0,2 201 302
Välittäjätilasto
Dataa ei löytynyt